(AGENPARL) – WORCESTER (MASSACHUSETTS), mer 28 aprile 2021 (Brotman Baty Institute for Precision Medicine) The University of Washington’s School of Medicine Brotman Baty Institute for Precision Medicine is collaborating with Illumina, Inc. (Nasdaq: ILMN) and GeneDx, Inc., a wholly owned subsidiary of BioReference Laboratories, Inc., an OPKO Health company, to study early detection of developmental differences in children.

Fonte/Source: https://www.eurekalert.org/pub_releases/2021-04/bbif-bbi042721.php

LEAVE A REPLY

Please enter your comment!
Please enter your name here